John,

Last March -- just as the COVID-19 pandemic was taking hold in the U.S. -- Bloomberg Philanthropies joined the State of Maryland and Johns Hopkins University to fund research into a possible treatment: plasma therapy.

Plasma therapy uses antibodies from previously infected patients to protect those who have become ill. After months of research and study, we now have a stronger understanding of how -- and when -- the treatment can help people battling COVID-19.

So what does the evidence say about the effectiveness of plasma therapy? Check out our latest Road to Recovery video to find out more:

In the video, Dr. Arturo Casadevall -- the leading researcher for plasma therapy at the Johns Hopkins Bloomberg School of Public Health -- explains the science behind the treatment, and reports on the studies that have taken place over the course of the pandemic.

Dr. Casadevall also explains that it's important to spread the word about plasma therapy because, for it to work, it requires donations from people who have recovered from COVID-19.

You can help by watching the video and sharing -- especially with someone who has recovered from COVID-19 and who might be able to donate plasma.

Share on Facebook
Share on Twitter
Share on LinkedIn

Thanks,

Bloomberg Philanthropies
 

P.S. -- Can you or someone you know donate plasma to fight COVID-19? Check out the U.S. FDA website to learn more about how you might be able to help: https://www.fda.gov/emergency-preparedness-and-response/coronavirus-disease-2019-covid-19/donate-covid-19-plasma.